HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Role of a homozygous A(TA)₇TAA promoter polymorphism and an exon 1 heterozygous frameshift mutation UGT1A1 in Crigler-Najjar syndrome type II in a Thai neonate.

Abstract
Crigler-Najjar syndrome is a rare autosomal recessive disease caused by mutations in the UGT1A1 gene. These mutations result in the deficiency of UGT1A1, a hepatic enzyme essential for bilirubin conjugation. This report describes the case of a 4-month-old boy with the cardinal symptoms of Crigler-Najjar syndrome type II. Molecular genetic analysis showed a homozygous UGT1A1 promoter mutation [A(TA)7TAA] and a heterozygous insertion of 1 adenosine nucleotide between positions 353 and 354 in exon 1 of UGT1A1 that caused a frameshift with a premature stop codon.
AuthorsP Nilyanimit, A Krasaelap, M Foonoi, V Chongsrisawat, Y Poovorawan
JournalGenetics and molecular research : GMR (Genet Mol Res) Vol. 12 Issue 3 Pg. 3391-7 (Sep 04 2013) ISSN: 1676-5680 [Electronic] Brazil
PMID24065680 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Codon, Nonsense
  • UGT1A1 enzyme
  • Glucuronosyltransferase
  • Bilirubin
Topics
  • Asian People (genetics)
  • Bilirubin (genetics, metabolism)
  • Codon, Nonsense (genetics)
  • Crigler-Najjar Syndrome (genetics, pathology)
  • Exons
  • Frameshift Mutation
  • Glucuronosyltransferase (genetics)
  • Heterozygote
  • Homozygote
  • Humans
  • Infant, Newborn
  • Male
  • Polymorphism, Single Nucleotide
  • Promoter Regions, Genetic

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: